Background: Stress is known to contribute to obesity and hypertension and both are considered to be primary risk factors for cardiovascular disease. Green coffee bean extract (GCBE) contains chlorogenic acid (CGA) which is attributed with several health benefits including anti-obesity and anti-hypertensive effects.
INTRODUCTION
The prefrontal cortex regulates human behaviour, cognition and emotion. Exposure to acute or chronic stress has been shown to impair these through the activation of calcium and potassium channels, weakening synaptic input and reducing neuronal firing 1 . Many people experience some level on a daily basis of acute or chronic stress, and it can impact on their well-being, sometimes through weight gain and/or hypertension. Coffee is one of the most frequently consumed nonalcoholic beverages and those wanting to adopt a healthier lifestyle may choose better options such as green tea or coffee. Green tea and green coffee bean extract have been shown to have several beneficial effects in reducing BP and body weight [2] [3] [4] [5] [6] and there is also the potential for green coffee to produce similar favourable properties. The two commonly known types of coffee, black and green coffee, differ in their roasting process; green coffee beans are usually unroasted whilst black coffee beans are roasted, and the latter results in a decrease in their antioxidant and chlorogenic acid (CGA, a polyphenol found in coffee and other botanicals) levels [7] [8] . Several fruits and vegetables rich in polyphenols have been reported to reduce blood pressure and possess many health benefits [9] [10] [11] [12] .
Green coffee bean extract (GCBE) contains CGA which has anti-obesity, anti-hypertensive properties and may also reduce glucocorticoids and vascular stiffness [7] [8] [9] . Moreover, CGA is the main ingredient in green coffee and GCBE which produces the desired effects. Other beneficial effects of CGA include possible neuroprotective properties such as in the prevention of Alzheimer's disease although there is limited evidence to support this and further research is needed for this end [13] [14] [15] [16] . Hypertension is a primary risk factor for coronary heart disease and cardiovascular disease (CVD) and the risks of these diseases can be reduced with simple lifestyle modifications such as a change in diet, an exercise regime or through drug therapies 17 . Alternatively, GCBE offers a natural diet based approach for reducing BP rather than the use of a drug based approach and may be considered to be more desirable. Suzuki et al. (2002) 17 first reported the antihypertensive properties of GCBE on spontaneously hypertensive rats that were given either single or long-term doses of GCBE. A single dose of GCBE (180, 360 and 720mg/kg) significantly decreased BP compared with the placebo, and there was a statistically significant decrease in BP that followed a dose dependant effect between each of the doses compared to the control. The effects of CGA observed in rats were later confirmed by Kozuma et al. (2005) 18 in humans with mild hypertension. They used 117 healthy volunteers who were given either a placebo or GCBE (46, 93 or 185mg/day) for 28 days. Intake of GCBE significantly decreased volunteer's BP (p<0.05 with 93mg and p<0.01 with 185mg) compared to the placebo group. Usually, high BP is associated with reduced arterial compliance but CGA may reduce both 14, 15 . Few studies choose to use a high dose of CGA which is an important area that should be considered. The link between weight reduction and CGA has been well documented and the mechanism for the weight loss effects attributed to CGA 19 . It has been shown to reduce and slow glucose absorption by inhibiting the action of glucose transporters in the small intestine which will lead to an improvement in glucose control and weight loss [20] [21] . There is no definitive conclusion as to how CGA reduces weight, but evidence exists to suggest that it plays a role in weight reduction. It is likely that CGA reduces weight by a number of mechanisms: Cho et al. (2010) 22 showed that CGA reduced activity of fatty acid synthase (FAS), HMG-CoA reductase, ACAT and increased fatty acid β-oxidation. They looked at mice on a normal diet, a high fat diet or a diet containing 0.02g/kg CGA over an eight week period. Those on the CGA diet showed lower amounts of each of the components that are used in fat production (FAS, HMG-CoA reductase and ACAT) and also had an increased rate of fatty acid β-oxidation compared with mice on the normal or high fat diet. The aims of this study were to assess whether heart rate, systolic and diastolic BP, and anthropometric measurements including weight and BMI are affected by GCBE short term use.
Materials and Method

Study Design
This was a single-blind, cross-over, placebocontrolled small trial. All measurements were taken in triplicate to improve reliability and the mean was calculated. Volunteers were asked to follow their usual diet and physical activity habits. Questionnaires and 2-day diet diaries, for one weekday and one weekend day, were done at baseline and after taking the GCBE, to determine volunteer's physical activity levels, salt and caloric intake. An increase or decrease of salt or calories may account for a change in weight, BP and anthropometric measures. Questionnaires were used to determine eligibility of the volunteers (see Table 1 ). An ethical approval was granted by Edinburgh University ethics committee, Edinburgh, UK and subjects were largely students and staff members. Measurements of heart rate, BP, height and weight were taken at baseline and again on days 7 and 21 to detect if the placebo (containing caffeine) or GCBE had caused any effects. There was a 7-day wash-out period, between days 8-14, to avoid a carry-over effect and to make sure that only either the caffeine or the GCBE was having an effect 23 .
On day 14, the groups switched the intervention protocol they were taking to the other arm of the study. The same equipment was used each time to avoid inaccuracies. Figure 1 shows the outline of the cross-over study design. Never or 1-3 times a week 1-2 cups a day 2-4 cups a day > than 4 cups a day
Do you drink alcohol? Yes No
If yes, how much and how often?
Study Population A total of 16 healthy volunteers (7 males, 9 females) were recruited and were placed into two groups. This number of was chosen because of the Ethics committee requirements for pilot studies. The number was thought to be sufficient for a pilot study. Volunteers were given randomly a participant number and those who had an even number were allocated to begin the GCBE first, whilst those who had an odd number began the placebo first. Volunteers signed a consent form after reading an information sheet about the study. Those who were caffeine sensitive and had a history of cardiovascular disease, kidney disease, diabetes or were smokers and pregnant females were excluded from the study. Also, only those who had a BMI of 18-35 kg/m 2 were included in the study and were asked to reduce caffeine containing drinks such as coffee, tea and fizzy drinks during the study, but none of these contain CGA. All data collected was stored electronically with a password and kept anonymous.
Figure 1: Shows the outline of the cross-over study design Baseline Measurements
Volunteers had their baseline measurements taken for BP (3 readings of systolic and diastolic BP were taken each time) using an A&D digital sphygmomanometer This is a very reliable device and applied by thousands of studies with errors of <0.1% mmHg), as well as height (m) using a Seca height measure and weight (kg) using a Salter weight measurement scale. The digital assessment of BP is regarded a very reliable and have been used by most research studies. BMI was then calculated as weight/(height) 2 . Volunteers were asked to remove their shoes and jackets for measurements. All measurements were taken on day 0, day 7 and day 21 to determine if the placebo or GCBE intake had caused any effect.
Green Coffee Bean Extract Intake
Volunteers were asked to take two 500mg GCBE (Nature's way premium extract, Nature Best, Tunbridge Wells, England) tablets per day, each containing 250mg of CGA and 12.5 mg of caffeine (total caffeine per day=25mg); one in the morning and one in the evening. The dose of 500mg of CGA was chosen because it was found to reduce BP and weight in previous other studies 19 .
Placebo Intake
When taking the placebo, volunteers were asked to take half a 50mg tablet of caffeine (Bayer pro-plus) per day. This was very closely matched the amount of caffeine in the 2 GCBE tablets taken during the intervention (25mg). As caffeine can cause weight loss, so the amount of caffeine in both the placebo and GCBE tablet should be similar as much as possible. Volunteers were further asked to take both interventions at the same time of the day.
Statistical Analysis
Variables were tested for normality on SPSS (version 21.0.0.2). All data were parametric and a student's twotail paired t-test was done in SPSS between volunteers measurements at baseline and both the GCBE and placebo. The test was done for weight, BMI, systolic and diastolic BP. Descriptive statistics were done in Excel 2010. Diet diaries were analysed using Windiet (2005) and a paired t-test was also calculated for mean caloric and sodium intake between baseline and whilst taking the GCBE. All the data were presented as mean±SD. Any p value ≤ 0.05 was considered to be significant.
Results and Discussion
Volunteer's Characteristics
All healthy volunteers (7 males and 9 females), aged between 19 and 32 year with a mean±SD of 24.6±3.3year were recruited and all completed the study. All were recruited for the study with exclusion criteria given above (Study population). No adverse effects to either the caffeine or GCBE were reported. Mean baseline, post caffeine and post GCBE values are shown in Table 1 . The main limitations of this study: the small sample size and thus the results may not reflect the true population and compliance was checked only verbally and there was no true way to know if the volunteers have taken all the tablets they were supposed to. A seven day period was allocated for each intervention with a week wash-out period in between. It would have been more desirable to use a longer intervention period and a longer wash-out period 24 . 25 showed that GCBE intake had significantly reduced body weight after taking an herbal ephedra and caffeine/day (n=167, P<0.001). Our study used more females than males and consequently the menstrual cycle may impact on weight changes. Other studies have included a greater percentage of males to obtain a more accurate representation of the effects of CGA on weight loss 26 .
GCBE have the potential to reduce weight which could benefit health. One mechanism stands out more in the literature for the effect of CGA plus caffeine on body weight was that due to the increase in resting energy expenditure and thermogenesis 21, 23, 25 . Most authors agree that CGA in GCBE slows absorption of glucose in the small intestine. If glucose absorption is reduced, the glucose blood level will be reduced improving glucose control and reducing weight. Interestingly, Gavrieli et al (2013) 27 have reported that a moderate coffee intake can effectively reduce energy intake in the following meal and during the whole day.
Effect of GCBE on Physiological Markers
Supplementing volunteers with GCBE had significantly reduced mean DBP. It decreased from baseline of 76.9± 9.1 to post GCBE of 72.6±5.9mmHg (p<0.001), and also SBP significantly decreased from a mean of 119.1±11.9 at baseline to 114.5±9.6 mmHg after taking GCBE (p=0.001). See Table 2 and figure 2. No significant decrease or changes were found in other physiological markers after the intake of GCBE (heart rate, energy intake or sodium intake). There were no significant differences between any baseline measurements and post placebo (caffeine) values (p values were all not significant and ranged from p=0.112 to p=0.578). The antihypertensive effects of GCBE seen in this study were similar to those found by Yamaguchi et al. (2008) 28 . In their randomized, double-blind study, they
showed that BP significantly decreased after 4 weeks of CGA intake in 203 volunteers (p<0.001). The present study has substantiated the work of Yamaguchi and collegues (2008) 28 , showing that GCBE, a natural nutraceutical reduces both systolic and diastolic BP. reported inconsistent results as far as the antihypertensive actions of GCBE. After a four month study they found no significant differences in the BP when volunteers took 140mg/day CGA. The drawback of their study was the small sample group (n=10), that might have produced a statistical error. Doses of 0.25%, 0.5% and 1% of CGA in the diet, were used for the long-term intervention and there was a statistically significant decrease in BP between each of the doses compared to the control diet, p<0.01 for 0.25% and p<0.001 for doses of 0.5% and 1%. Therefore, CGA may play some role in down-regulating FAS, HMG-CoA reductase and ACAT whilst upregulating fatty acid β-oxidation on short term basis and could be on long term use 17 . Hypertension can cause several serious consequences; kidney disease, diabetes, stroke, heart disease and many others. Each 2 mmHg rise in systolic BP corresponds to a 7% increased risk of mortality from heart disease and a 10% increased risk of stroke 31 . Taking GCBE has been shown to reduce BP and possibly its associated risks. It is recommended that more extensive human trials on the benefits of GCBE for hypertensive people should be conducted. Consumption of Green Coffee and GCBE rich in CGA has been reported to reduce BP and BMI by Influencing 11β-HSD1 Enzyme Activity through the reduction of the stress hormone level, cortisol 7, 32 . However, some studies have shown that increased intake of coffee and caffeine increased blood pressure within the healthy physiological levels, in a gender specific manner [33] [34] [35] . Other researchers found no significant effects of coffee consumption on BP [36] [37] . The volunteers diet diaries showed that there was no significant difference in the salt intake of participants between baseline and whilst taking the GCBE. Any significant reduction in salt intake may have accounted for a reduction in BP and thus the reduction in the volunteers BP was most likely a consequence of the GCBE intake. Throughout the day BP will vary, however, participants were unable to have their measurements taken at the same time of the day due to inconvenience. Therefore, circadian changes in BP may mean the results might be questionable, and to improve the study, the volunteers BP should be taken at the same time of day or a 24 hour BP monitor could be employed. Physical Activity and Diet Diet diaries were used to determine if average baseline sodium and caloric intake was significantly different from the average values whilst taking the GCBE. A physical activity questionnaire was used to determine if there was a change in physical activity at baseline and whilst taking the GCBE. Analysis of diet diaries showed that there was no significant difference in the sodium and caloric intake between baseline and GCBE values. There was also no significant difference in physical activity between baseline and whilst taking the GCBE. It follows that the decrease in weight was not due to a change in diet or physical activity but due to the intake of GCBE rich in CGA. Questionnaires and diet diaries were used to determine volunteer's physical activity levels and caloric intake, and this technique is considered to be the norm in such studies. No significant changes in these measures were found between baseline and post GCBE, therefore the decrease in body weight may be attributed to the GCBE intake. 
Conclusions and Future Research
This study has shown that for normotensive individuals, short term dietary supplementation with GCBE can significantly decrease systolic and diastolic BP. Also a mean decrease was observed for body weight and BMI. Only a seven day intervention was used and a more significant change may have arisen if the study duration was extended over a longer period. Further research using a larger sample size and longer intervention period, for GCBE intake is warranted to clarify the effects in overweight and obese subjects, and whether salivary stress hormones will be reduced during GCBE intake. We also suggest that future studies should look at the effects of GCBE intake in mildly hypertensive and hypertensive patients. Future trials should also use a longer study than the one adopted in the present study. In addition, it may be beneficial to carry out research on those who have a BMI of >30kg/m 2 as a possible weight loss method, as most studies tend to use patients who have normal BMI.
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